Medtronic, Inc.

Valentx, Inc.

Transneuronic, Inc.

Roland C Maude-Griffin

Warren L Starkebaum

Charlene X Yuan

Luiz Geraldo Pivotto

Johann J Neisz

Jon St Germain

Cole Chen

Sean Miller

Elizabeth D Firestone

Christopher M Hobot

John E Burnes

Orhan Soykan

David A Jenkins

Carl A Schu

Jiande Chen

Rebecca L Poindexter

Daniel Bloomberg

A system and method for controlling a monitoring mode or treatment mode of an implantable medical device based on the detection of an external signal. The system and related method allow for more frequent monitoring of medical parameters at times where more frequent monitoring is necessary, such as during or after a dialysis session, with less frequent monitoring at other times, allowing for a more efficient medical device. The invention also allows for the frequency or mode of treatment by the implantable medical device, or the transmission of data from the implantable medical device to be controlled based on the external signal.

Monitoring mode of an implantable medical device

Gastrointestinal bypass devices are described. In one embodiment, a gastrointestinal bypass device may include an anchoring membrane configured to be attached to a wall of an esophagus with a tissue anchor placed through the anchoring membrane. The anchoring membrane may be configured to be pierced to allow the tissue anchor to be placed through the anchoring membrane. Methods for attaching a device to a tissue wall are described. In one embodiment, a method may include forming a bulge in an anchoring membrane of the device and the tissue wall, piercing the bulge from a first side of the anchoring membrane and a first side of the tissue wall, placing a second retention element of a tissue anchor on a second side of the tissue wall, and, placing a tension element of the tissue anchor through the anchoring membrane and the tissue wall. The tension element may be coupled to the second retention element. The method may further include placing a first retention element on the first side of the anchoring membrane. The first retention element may be coupled to the tension element.

Devices and methods for gastrointestinal bypass

Delivery devices are described. In one embodiment, a delivery device includes a catheter and a sealing pad coupled to an outer surface of the catheter. The delivery device may further include a recess formed in an outer surface of the catheter. The sealing pad may be coupled in the recess. Methods for delivering a tubular device are described. In one embodiment, a method may include inserting a distal end of a catheter into a lumen of a tubular device. The catheter may include a sealing pad coupled to an outer surface of the catheter. The method also includes positioning the sealing pad inside a drawstring coupled circumferentially to the tubular device, and cinching the drawstring around the catheter at the sealing pad to couple the tubular device to the catheter.

In some examples, the disclosure relates to a systems, devices, and techniques for delivering electrical stimulation therapy to a patient. In one example, the disclosure relates to a method including delivering a series of pulses with alternating pulse polarities to a gastrointestinal tract of a patient. The series of pulses includes at least a first pulse of a first polarity, a second pulse of a second polarity, and a third pulse of the first polarity, where the first, second and third pulses are delivered in direct succession and in that order. The first and second pulses are separated by a first time delay and the second and third pulses are separated by a second time delay. In some examples, each of the first and second time delays depend on the frequency that the series of pulses are delivered.

Waveforms for electrical stimulation therapy

The disclosure is directed to gastric stimulation programmers, stimulators and methods for controlling delivery of gastric stimulation therapy to maintain the efficacy of the therapy over time. Maintaining the efficacy of gastric stimulation therapy may be possible by implementing one or more anti-desensitization features in a gastric stimulation controller or stimulator. As electrical stimulation therapy is continuously delivered to a patient, the stimulated tissue may become desensitized to the electrical stimulation therapy such that the beneficial effect of the electrical stimulation is diminished. Once desensitization occurs, the affected tissue may not respond favorably to electrical stimulation therapy. Application of one or more anti-desensitization features to control gastric stimulation therapy may reduce or prevent desensitization and effectively extend the efficacy of the therapy over time.

Gastric electrical stimulation with lockout interval anti-desensitization feature

In some examples, electrical stimulation therapy is delivered to support obesity management. The electrical stimulation therapy is configured to cause at least partial gastric distention. Gastric distention tends to induce a sensation of fullness and thereby discourages excessive food intake by the patient. The electrical stimulation therapy may be delivered to the gastrointestinal tract of the patient by electrodes deployed by one or more implantable leads coupled to an electrical stimulator. The electrical stimulator delivers stimulation pulses having a pulse width in a range found to be effective in causing gastric distention.

Electrical stimulation therapy to promote gastric distention for obesity management

Gastric electrical stimulation with multi-site stimulation anti-desensitization feature

Gastric electrical stimulation with therapy window anti-desensitization feature

Method for screening patients to predict which patients at risk of a medical disorder, such as morbid obesity, gastrointestinal problems, or gastroesophageal problems, will be responders, and conversely, which patients will not, to achieve a favorable outcome from therapy for that disorder. This method supports an intervention strategy for patients having weight or gastrointestinal problems that will cut health costs. It enables patients and care-givers alike to more efficiently use their time, efforts and resources by enabling an early selection of an appropriate treatment modality for a given patient. Its application also extends to other implantable medical devices and therapies using them.

Method for screening and treating patients at risk of medical disorders

Growing community of inventors

Edina, MN, United States of America

Roland C Maude-Griffin